Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX

BlackRock, Inc. reported a 7.80% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 17, 2025

BlackRock, Inc. reported a 7.80% stake in Syndax Pharmaceuticals, Inc., 6,744,049 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).

Stake
7.80%
Shares
6,744,049
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.80%6,744,049

Source

View original at SEC

Related